Filing Details

Accession Number:
0001415889-23-005666
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-31 16:21:47
Reporting Period:
2023-03-29
Accepted Time:
2023-03-31 16:21:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1707685 Marie Christine Utter C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Svp, Finance & Cao No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-29 4,688 $40.45 42,747 No 4 M Direct
Common Stock Disposition 2023-03-29 3,247 $47.80 39,500 No 4 S Direct
Common Stock Disposition 2023-03-29 1,441 $47.78 38,059 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-03-29 4,688 $40.45 4,688 $40.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-09-23 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $51.00 2025-01-02 17,800 17,800 Direct
Common Stock Stock Option (Right to Buy) $33.02 2029-01-21 4,321 4,321 Direct
Common Stock Stock Option (Right to Buy) $33.02 2029-01-21 371 371 Direct
Common Stock Stock Option (Right to Buy) $51.16 2030-01-28 23,800 23,800 Direct
Common Stock Stock Option (Right to Buy) $66.49 2031-01-05 50,750 50,750 Direct
Common Stock Stock Option (Right to Buy) $38.10 2032-01-06 43,500 43,500 Direct
Common Stock Stock Option (Right to Buy) $39.42 2033-01-04 32,500 32,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-01-02 17,800 17,800 Direct
2029-01-21 4,321 4,321 Direct
2029-01-21 371 371 Direct
2030-01-28 23,800 23,800 Direct
2031-01-05 50,750 50,750 Direct
2032-01-06 43,500 43,500 Direct
2033-01-04 32,500 32,500 Direct
Footnotes
  1. This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on February 24, 2023.
  2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Currently exercisable.
  4. This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
  5. Represents an option award of 33,250 options and an option award of 17,500 options. These option awards were each granted on January 6, 2021, and each vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
  6. This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
  7. This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.